Epigenomics of Common Diseases14 - 17 November 2017Wellcome Genome Campus, Hinxton, UK
Deadlines (at 23:59 UTC):
- Bursary Deadline Closed
- Abstract Deadline Closed
- Registration Deadline Closed
Registration opens soon.
Email for updates.
The 7th Epigenomics of Common Diseases conference will bring together leading scientists for the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving area.
Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference data. Associations between epigenetic variation, a variety of risk factors and the development of many diseases continue to emerge but causality has, in many instances, not yet been established.
This meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease. This year’s meeting will emphasise recent studies on epigenetics of ageing, brain diseases, chromatin architecture, regulatory networks, and computational epigenomics. There will also be a special session on the approaches needed to demonstrate causality in epigenetic studies.
The conference will start at approximately 12.30 on Tuesday, 14 November and close at approximately 14.00 on Friday, 17 November 2017.
Topics will include:
- Epigenomics of ageing
- Evolution and epigenetics
- Inheritance of epigenetic programmes
- Population and clinical epigenetics
- Epigenomics of brain disease
- Causality in epigenetic studies
- 4D nucleome
- Enhancers and regulatory networks
- Computational epigenomics and bioinformatics
- New epigenomic technologies
Click here for the conference programme.
- Organisers / Speakers
Scientific programme committee
Edith Heard Institut Curie, France
Doug Higgs University of Oxford, UK
Caroline Relton University of Bristol, UK
Art Petronis University of Toronto, Canada
Genevieve Almouzni Institut Curie, France
Wendy Bickmore University of Edinburgh, UK
Peter Adams University of Glasgow, UK
Ewan Birney EMBL-EBI, UK
George Davey-Smith University of Bristol, UK
Mandy Fisher MRC Clinical Sciences Centre, UK
Anja Groth University of Copenhagen, Denmark
Bas Heijmans Leiden University Medical Center, The Netherlands
Doug Higgs University of Oxford, UK
Steve Horvath University of California, Los Angeles, USA
Nada Jabado Montreal Childrens Hospital, Canada
Tomas Marques-Bonet Universitat Pompeu Fabra, Spain
Matthias Merkenschlager MRC Clinical Sciences Centre, UK
Marcelo Nobrega University of Chicago, USA
Duncan Odom Cancer Research UK Cambridge Institute, UK
Tomi Pastinen Children’s Mercy Kansas City, USA
Tatjana Sauka Spengler University of Oxford, UK
Anne Schaefer Mount Sinai School of Medicine, USA
Laura Hubbard Wellcome Genome Campus, UK
- Registration / Accommodation
Student No accommodation £365 Student On site twin accommodation £517 Student On site single accommodation £610 Academic No accommodation £465 Academic On site twin accommodation £617 Academic On site single accommodation £710 Commercial No accommodation £565 Commercial On site twin accommodation £717 Commercial On site single accommodation £810
The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
Accommodation is provided for the nights of 14, 15 16 November 2017.
Please note: there is limited onsite accommodation and this will be
allocated on a first-come, first-served basis. Therefore, early
registration is recommended.
If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.
Contact the conference organiser if you require a letter to support a
travel visa application. Please note: letters will only be provided to
Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
Please visit the following websites for further information:
UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/
Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/
We welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.
Abstracts will only be considered from registered delegates. Please use our online abstract submission system and follow the instructions given to ensure your abstract is submitted correctly. All abstracts must be submitted by the deadline. If you are intending to submit more than one abstract, please contact the conference organiser prior to registration.
The scientific programme committee will assess your abstract after the deadline has passed and you will be notified whether you have been selected for an oral or poster presentation.
Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-portrait) of printed material. Accepted abstracts will appear in the conference programme book and poster boards will be allocated at the conference.
Abstract deadline: Closed
Abstract guidelines can be viewed here.
A limited number of registration bursaries are available for PhD students to attend this conference (up to 50% of the registration fee) from Wellcome Genome Campus Scientific Conferences.
The following documents will need to be provided:
- Covering letter
- Letter from supervisor
To apply, please contact the conference organiser.
Bursary deadline: Closed